Harbour BioMed Collaborates With Lannacheng To Advance Next-Generation Radionuclide Drug Conjugates
(RTTNews) - Harbour BioMed announced that it has entered into a long-term strategic collaboration with Yantai Lannacheng Biotechnology Co., Ltd. T...
29 Dec 03:12 · finanzen.at